
Latest Articles
SARCLISA® (isatuximab) in Clinical Practice Professor Karthik Ramasamy: Frail Case Study Review
SARCLISA® (isatuximab) in Clinical Practice Dr Sally Moore: Borderline Case Study Overview
SARCLISA® (isatuximab) in Clinical Practice Professor Karthik Ramasamy: Borderline Case Study Review

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)
Read to learn more about the burdens of uncontrolled AD.

The Hidden Impact of Cumulative Life Course Impairment (CLCI) in Dermatology: An Overview
Read to learn more about the concept of CLCI, how it manifests in atopic dermatitis and its impact on patients.

When to Start People with Diabetes on Insulin
Key indicators and timing for insulin initiation in Type 2 diabetes care pathways

Practical Insulin Transition Guide for Nurses: Titration and Patient Support
.png)
Head to Head Studies
Trurapi®▼ (insulin aspart 100 units/mL)
MAT-XU-2305061 (v2.0) Date of preparation: February 2024